BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kobayashi M, Hazama S, Takahashi K, Oba K, Okayama N, Nishioka M, Hinoda Y, Oka M, Okamoto K, Maeda H, Nakamura D, Sakamoto J, Mishima H. Is there diversity among UGT1A1 polymorphism in Japan. World J Gastrointest Oncol 2012; 4(7): 170-175 [PMID: 22848786 DOI: 10.4251/wjgo.v4.i7.170]
URL: https://www.wjgnet.com/1007-9327/full/v4/i7/170.htm
Number Citing Articles
1
Satoshi Yamasaki, Kazuki Tanimoto, Kentarou Kohno, Masanori Kadowaki, Ken Takase, Seiji Kondo, Akira Kubota, Morishige Takeshita, Seiichi Okamura. UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecanAnnals of Hematology 2015; 94(1): 65 doi: 10.1007/s00277-014-2170-5
2
Hiromichi Maeda, Shoichi Hazama, Abdiev Shavkat, Ken Okamoto, Koji Oba, Junichi Sakamoto, Kenichi Takahashi, Masaki Oka, Daisuke Nakamura, Ryouichi Tsunedomi, Naoko Okayama, Hideyuki Mishima, Michiya Kobayashi. Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese PopulationsMolecular Diagnosis & Therapy 2014; 18(3): 333 doi: 10.1007/s40291-014-0083-6
3
Yoshitaka Nishikawa, Masashi Kanai, Maiko Narahara, Akiko Tamon, J. B. Brown, Kei Taneishi, Masahiko Nakatsui, Kazuya Okamoto, Yu Uneno, Daisuke Yamaguchi, Teruko Tomono, Yukiko Mori, Shigemi Matsumoto, Yasushi Okuno, Manabu Muto. Association between UGT1A1*28*28 genotype and lung cancer in the Japanese populationInternational Journal of Clinical Oncology 2017; 22(2): 269 doi: 10.1007/s10147-016-1061-2
4
Shoichi Hazama, Hideyuki Mishima, Ryouichi Tsunedomi, Yusuke Okuyama, Takeshi Kato, Ken‐ichi Takahashi, Hiroshi Nozawa, Hideaki Ando, Michiya Kobayashi, Hiroyoshi Takemoto, Naoki Nagata, Shinsuke Kanekiyo, Yuka Inoue, Yoshihiko Hamamoto, Yusuke Fujita, Yuji Hinoda, Naoko Okayama, Koji Oba, Jun‐ichi Sakamoto, Masaaki Oka. UGT1A1*6,1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI‐treated metastatic colorectal cancer in two prospective studies in JapanCancer Science 2013; 104(12): 1662 doi: 10.1111/cas.12283
5
Dan Liu, Jian Li, Jing Gao, Yanyan Li, Rui Yang, Lin Shen. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysisBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3406-2
6
Hiromichi Maeda, Shoichi Hazama, Shigeyoshi Iwamoto, Koji Oba, Ryouichi Tsunedomi, Naoko Okayama, Yutaka Suehiro, Takahiro Yamasaki, Yuki Nakagami, Nobuaki Suzuki, Hiroaki Nagano, Junichi Sakamoto, Hideyuki Mishima, Naoki Nagata. Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin‑based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trialsOncology Letters 2019;  doi: 10.3892/ol.2019.10787
7
Tomoko Horinouchi, Kaori Maeyama, Masashi Nagai, Masami Mizobuchi, Yasuko Takagi, Yuka Okada, Takeshi Kato, Mio Nishimura, Yoko Kawasaki, Mieko Yoshioka, Satoshi Takada, Hisayuki Matsumoto, Yuji Nakamachi, Jun Saegusa, Sachiyo Fukushima, Kazumichi Fujioka, Kazumi Tomioka, Hiroaki Nagase, Kandai Nozu, Kazumoto Iijima, Noriyuki Nishimura. Genetic Analysis of UGT1A1 Polymorphisms Using Preserved Dried Umbilical Cord for Assessing the Potential of Neonatal Jaundice as a Risk Factor for Autism Spectrum Disorder in ChildrenJournal of Autism and Developmental Disorders 2022; 52(2): 483 doi: 10.1007/s10803-021-04941-w
8
Ronald Kong, Oscar L. Laskin, Diksha Kaushik, Fengbin Jin, Jiyuan Ma, Joseph McIntosh, Marcio Souza, Neil Almstead. Ataluren Pharmacokinetics in Healthy Japanese and Caucasian SubjectsClinical Pharmacology in Drug Development 2019; 8(2): 172 doi: 10.1002/cpdd.645